Trial · NCT02034110
Adverse events6,656
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 6,656
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Anaplastic Thyroid Cancer (ATC) (On-Treatment) | 12 | 36 | |
| other | Anaemia | Blood and lymphatic system disorders | Biliary Tract Cancer (BTC) (On-Treatment) | 10 | 43 | |
| other | Anaemia | Blood and lymphatic system disorders | Gastrointestinal Stromal Tumor (GIST) (On-Treatment) | 0 | 1 | |
| other | Anaemia | Blood and lymphatic system disorders | Low Grade (WHO G1/G2) Glioma (LGG) (On-Treatment) | 4 | 13 | |
| other | Anaemia | Blood and lymphatic system disorders | High Grade (WHO G3/G4) Glioma (HGG) (On-Treatment) | 9 | 45 | |
| other | Anaemia | Blood and lymphatic system disorders | Adenocarcinoma of the Small Intestine (ASI) (On-Treatment) | 0 | 3 | |
| other | Anaemia | Blood and lymphatic system disorders | Hairy Cell Leukemia (HCL) (On-Treatment) | 10 | 55 | |
| other | Anaemia | Blood and lymphatic system disorders | Multiple Myeloma (MM) (On-Treatment) | 3 | 10 | |
| other | Anaemia | Blood and lymphatic system disorders | Anaplastic Thyroid Cancer (ATC) (Post-treatment Survival Follow-up) | 0 | ||
| other | Anaemia | Blood and lymphatic system disorders | Biliary Tract Cancer (BTC) (Post-treatment Survival Follow-up) | 0 | ||
| other | Anaemia | Blood and lymphatic system disorders | Gastrointestinal Stromal Tumor (GIST) (Post-treatment Survival Follow-up) | 0 | ||
| other | Anaemia | Blood and lymphatic system disorders | Low Grade (WHO G1/G2) Glioma (LGG) (Post-treatment Survival Follow-up) | 0 | ||
| other | Anaemia | Blood and lymphatic system disorders | High Grade (WHO G3/G4) Glioma (HGG) (Post-treatment Survival Follow-up) | 0 | ||
| other | Anaemia | Blood and lymphatic system disorders | Adenocarcinoma of the Small Intestine (ASI) (Post-treatment Survival Follow-up) | 0 | ||
| other | Anaemia | Blood and lymphatic system disorders | Hairy Cell Leukemia (HCL) (Post-treatment Survival Follow-up) | 0 | ||
| other | Anaemia | Blood and lymphatic system disorders | Multiple Myeloma (MM) (Post-treatment Survival Follow-up) | 0 | ||
| other | Leukopenia | Blood and lymphatic system disorders | Anaplastic Thyroid Cancer (ATC) (On-Treatment) | 2 | 36 | |
| other | Leukopenia | Blood and lymphatic system disorders | Biliary Tract Cancer (BTC) (On-Treatment) | 2 | 43 | |
| other | Leukopenia | Blood and lymphatic system disorders | Gastrointestinal Stromal Tumor (GIST) (On-Treatment) | 0 | 1 | |
| other | Leukopenia | Blood and lymphatic system disorders | Low Grade (WHO G1/G2) Glioma (LGG) (On-Treatment) | 1 | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02034110/events